FDA approves Moderna's mRNA flu vaccine after initially refusing to review it
The FDA has approved Moderna's mRNA seasonal flu vaccine, reversing an initial decision not to review it. This marks a significant development in vaccine technology.
Engadget
- Entities
- Moderna
- mRNA Technology
- Vaccines
Original source
This article was reported and published by Engadget. feed.gg links to it as part of a story cluster — full text, images and rights remain with the publisher.